CNS Conference | CNS Conferences | Cognitive Neuroscience Conferences | CME Conference | Europe Meetings | USA | Middle East | 2016 | Asia

Theme: Accelerate the Diagnosis, Prevention & Management of CNS Disorders

CNS 2016

Scientific Programme

Renowned Speakers

Dionisio Figueiredo Lopes
Hospital de Urgencia Otavio Lage, Brazil

Joanna Strosznajder
Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

Hiroyuki Nakase
Nara Medical University, Japan

Sevinj Hamidova Abisalam
Grand Hospital and stroke and Headache Centre, Azerbaijan

Claire Donnellan
Trinity College Dublin, Ireland

Abdolreza Esnaashari
Akershus University Hospital, Norway

Aguinaldo Pereira Catanoce
Pontificia Catholica University of Campinas, Brazil

Adriana Gini
San Camillo-Forlanini Medical Center, Italy

Wai Kwong Tang
The Chinese University of Hong Kong, Hong Kong SAR, China

Dmitri Rusakov
University College London, UK

Ahmed Al Jishi
McGill University Health Center, Canada

Ayman Tourbah
University Hospital of Rheims, France

CNS 2016

We invite all the participants from all over the world to attend the 2^nd International Conference on Central Nervous System Disorders and Therapeutics which is held during December 05-07, 2016 at Dubai, UAE.

A central nervous system disorder can affect either the spinal cord (myelopathy) or brain (encephalopathy), both of which are part of the central nervous system. The nervous system is vulnerable to various disorders. It can be damaged by the following Trauma, infections, blood flow disruption and tumours etc.

Track 1: Central Nervous System Disorders

Central Nervous System may be defined as the system which is made up of the brain and spinal cord. The CNS is vulnerable to various disorders. CNS can be damaged by the following: Trauma, Infections, Degeneration, Structural defects, Tumours, Blood flow disruption, Autoimmune disorders etc.

Approximately 22 million patients suffer from various forms of dementia, two thirds of which are related to Alzheimer’s. The WHO estimates the number of people suffering from multiple sclerosis worldwide at 2.5 million. As for schizophrenia, 1percent of the world’s population may be at risk.

8th European Neurology Congress September 21-23, 2016 Amsterdam, Netherlands; International Conference on Spine and Spinal Disorders June 30 - July 02, 2016 Valencia, Spain; 2nd International Conference on Brain Disorders and Therapeutics October 26-28, 2016 Chicago, USA; 5th International Conference on Alzheimer’s Disease and Dementia September 29-October 01, 2016 London, UK; 9th Global Neuroscience Conference November 21-23, 2016 Melbourne, Australia; European Skull Base Congress during 26 May 2016- 28 May 2016 at Berlin, Germany 2016; Alzheimer's Disease Congress during 07 Jun 2016- 09 Jun 2016 at London, United Kingdom; International Conference on Sleep Spindling during 12 May 2016- 14 May 2016 at Budapest, Hungary; 3rd International Conference on Treatment of Dystonia during 04 May 2016- 07 May 2016 at Hanover, Germany; Advances in Clinical Neuroimmunology during 17 Jun 2016- 18 Jun 2016 at Warsaw, Poland; American Association of Neurological Surgeons; American Academy of Neurology; World Federation of Neurology; Stroke Association; Spanish Society of Neurology

Track 2: Cerebral Disorders

Cerebral dysfunction may be focal or global. Focal dysfunction is caused by structural abnormalities and global dysfunction is caused by toxic-metabolic disorders and diffuses inflammation, vasculopathy, major trauma, or disseminated cancer; these diseases affect multiple dimensions of cerebral function.

Every year, an estimated 30,000 people in the United States experience a ruptured cerebral aneurysm and as many as 6percent may have an un-ruptured aneurysm.

Track 3: Neuronal Disorders

Neuronal Disorders may be defined as the disorders of the Brain, Spine and nerves that connect them. For example: Alzheimer's disease (AD) Epilepsy, Multiple sclerosis etc.

According to World Health Organization report- various types of neurodegenerative disorders affect millions of people around the world, including 25 million that suffer from Parkinson disease and 327 million who experience headaches and migraines.

Track 4: CNS and Neuro Surgery

Neurosurgery may be defined as the surgical specialty that is concerned with the diagnosis and surgical treatment of the CNS and Peripheral Nervous System. It is also known as Neurological Surgery. It is performed by a physician called neurosurgeon. Based on nature of disorders or diseases, neurosurgeons provide operative and non-operative care. It helps to treat patients with brain tumour, head and spinal cord injury. Types of Neurosurgery include: I).Endovascular Neurosurgery, II).Oncological Neurosurgery III). Stereotactic Neurosurgery so on.

Track 5: Neurochemical Transmission

A Neuron communicates its electrical activity to other cells by releasing chemicals at the Junction of the two cells, that process is known as Neurochemical transmission. The chemical substances which transfer an electrical impulse from a nerve cell to its target cell are known as neurotransmitters.

Track 6: Neuro Oncology and CNS

Neuro-oncology defines the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. For example: glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumours etc. Most Commonly used treatments in neuro-oncology are Radiotherapy, Chemotherapy, Corticosteroids and Neurosurgical Interventions.

Track 7: Cognitive Neurology

Cognitive neurology is a scientific study of neural mechanism underlying cognition. Cognitive Neurology is concerned with the diagnosis and treatment of diseases that affect memory and other ‘cognitive’ faculties (such as language, perception, planning-ability and social comportment). Cognitive neuroscience is at the intersection of psychology and neuroscience, but it also overlaps with physiological psychology, neuropsychology and cognitive psychology. This combines the theories of cognitive psychology & computational modelling with experimental data about the brain.

Track 8: Spinal Cord

The spinal cord refers as the main pathway for information connecting/transferring to the brain and peripheral nervous system. The spinal cord is also known as the large group of nerves which runs through the centre of the spinal cord and carries messages between the brain and the entire body. Spinal disorders may be seen in individuals irrespective of their age-Chiari malformation in infants to spinal stenosis in the elderly. The increase in population with spinal diseases has met with a leap in the advancements in diagnostic and treatment techniques. The commonly used tools in diagnosing spinal disorders are as follows: X rays, MRI, CT and DEA etc.

Track 9: Signal Transduction and CNS

Transduction may be defined as the method that converts a sensory signal to an electrical signal to be processed in a specialized area in the brain.

The brain has it specific processing regions that are dedicated to processing the information which has previously passed through the thalamus for both motor and sensory signals. Growth Factor and Cytokine receptors plays very important role in the activation of the signal transduction.

Track 10: Genesis of Neurons

Neurogenesis defines the process by which neurons are generated from neural stem cells and progenitor cells. Many different varieties of excitatory & inhibitory neurons are generated from different kinds of neural stem cells. The molecular and genetic factors influencing genesis of neuron notably include the Notch Signalling pathway, and many genes have been linked to Notch Signalling pathway regulation. It has been found to occur in two brain regions: the subventricular zone and the hippocampus.

Track 11: Neuro-pharmaceutics

Neuro-pharmaceutics studies focuses on discovery of therapeutic targets, and then translating those discoveries into drug and therapy development. It is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier.

Track 12: Clinical aspects of CNS

Clinical Aspects relating to or based on work done with real patients: of or relating to the medical treatment that is given to patients in hospitals, clinics, etc. It involves direct observation of the patient and based on or characterized by observable and diagnosable symptom. For example: Tumours of the Central Nervous System, Clinical Aspects of CNS Cysticercosis, Basic and Clinical Aspects of Malignant Melanoma etc.

Track 13: Case Study on CNS

Neurology and Neuroscience is the special branch of medical Sciences that deals primarily with the disorders in the CNS. Neurophysiology defined as a union of both neurology and physiology and it studies the functioning of the nervous system.

Track 14: Clinical Trials on CNS

With an ever increasing average life expectancy, Neurological and CNS Disorders are becoming more prevalent in society. The economic and social costs of Neurological and CNS Disorders to society are huge. Many big pharmaceutical companies have moved away from CNS and Neurology research.

This meeting will give delegates an opportunity to gain additional knowledge and insights into the best practices in clinical trials, as well as addressing the challenges in CNS and Neurology research and by looking at the latest preclinical and clinical studies.

Track 15: CNS Biomarkers

The term Biomarker can be defined as a measurable indicator of some biological state or condition. A biomarker can also be known as a biological biomarker.

CNS 2016 conference focuses on the development of CNS biomarkers for drugs and diagnostics from Cerebrospinal fluid and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative diseases will be presented on disease areas such as Alzheimer's and Parkinson's.

Track 16: Perspective in Neuroscience and Neurology

The neuroscience perspective relates to the way that people act in terms of how they came to be. It deals with the scientific study of the nervous system and recognized as the branch of biology. On the other hand, neurology perspective deals with the branch of medicine dealing with the disorders of nervous system, diagnosis and treatment of all kind of diseases in the central nervous system and peripheral nervous system.

Track 17: Drug Metabolism in Drug Design

The term “Drug metabolism” refers the metabolic breakdown of drugs by living organisms, usually through specialized enzymatic systems. It is divided into three phases: I). Enzymes such as cytochrome P450 oxidases introduce reactive or polar groups into xenobiotic II). Modified compounds are then conjugated to polar compounds III). Conjugated xenobiotic may be further processed, before being recognised by efflux transporters and pumped out of cells.

CME Accreditation Statement:

This activity has been approved for 24 AMA PRA Category 1 Credit™

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Theme: Accelerate the Diagnosis, Prevention & Management of CNS disorders

ConferenceSeries Ltd organizes conferences all around the world in 2016, here It is our pleasure to invite you to Neurology conference entitled “2nd International Conference on Central Nervous System Disorders and Therapeutics” during December 05-07, 2016 at Dubai, UAE. The main theme of our conference is "Accelerate the Diagnosis, Prevention & Management of CNS disorders" which covers wide range of critically important sessions.

Overview of CNS Disorders:

A central nervous system disease can affect either the spinal cord (myelopathy) or brain (encephalopathy), both of which are part of the central nervous system. The nervous system is vulnerable to various disorders. It can be damaged by the following Trauma, infections, blood flow disruption, tumours, autoimmune disorders etc. Disorders of the central nervous system may involve the following:

· Vascular Disorders: Stroke, Transient ischemic attack (TIA), Subarachnoid hemorrhage, Subdural hemorrhage and Hematoma, and Extradural haemorrhage

· Infections: Meningitis, Encephalitis, and epidural abscess

· Structural disorders: Brain or Spinal cord injury, Bell's palsy, Cervical spondylosis, Carpal tunnel syndrome, Brain or Spinal cord tumors

· Functional disorders: Headache, Epilepsy, Dizziness, and Neuralgia

· Degenerative disorders: Parkinson disease, Multiple sclerosis, Amyotrophic lateral sclerosis (ALS), Huntington chorea, and Alzheimer disease.

In addition, the geographical distribution of CNS disorder and market across the US, the top five countries of Europe and in Japan. The report also includes insights into the CNS disorder R&D product pipeline and explores the competitive landscape including major players in CNS disease market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in CNS disorder therapeutics market.

Why to attend?

2^nd International Conference on Central Nervous System Disorders and Therapeutics to bring together worldwide distinguished academics in the field of Neuro-oncologist, Neuropharmacology, Neurology, Neuropediatricians, Pediatric Oncologists, Neurosurgeons, Neurophysiologists, Neuroscience Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of CNS disorders to Patients. Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery

The aim of the Conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

Target Audience

Directors, Head of Department, Professors, Industrial Researchers, Neuro-oncologist, Neuropediatricians, Neurophysiologists, Neurosurgeons, Neurologist, Neuroradiologist, Neuro-Pathologists, Rehabilitation Specialists , Nurses, Neuroscience Researchers and Students from academia in the research of CNS disorders.

Target Audience:

Academia: 65%

Industry: 25%

Others: 10%

Theme: Accelerate the Diagnosis, Prevention & Management of CNS Disorders

About the Conference:

CNS-2016 welcomes attendees, presenters, and exhibitors from all over the world to Dubai, UAE. We are delighted to invite you all to attend and register for the“2^nd International Conference on Central Nervous System Disorders and Therapeutics” which is going to be held during December 05-07, 2016 in Dubai, UAE.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the CNS 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the CNS -2016 organizing committee look forward to meeting you in Dubai, UAE.

For more details please visit- http://cns.conferenceseries.com/

Importance and Scope:

2^nd International Conference on Central Nervous System Disorders and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of CNS 2016.Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about CNS 2016 and its allied areas.

Why Dubai???

Dubai is the most populated city in the UAE with residents of 2.2 million. Dubai is global business city and cultural hub of the Middle East and the Persian Gulf region. It is one of the countries of MENA which has international network of research with higher-education Institutions, transport, business, communication, events and conference hub bridging healthcare professionals from the seven continents annually to collaborate and exchange knowledge and research.

Dubai’s attraction lies in the contrast between the ultra-modern and the enchantingly traditional, which gives the city a personality like no other and visitors a variety of experiences to choose from. From desert oases and unspoiled beaches, camel races and old wind towers, to top-class shopping opportunities, avant-garde architecture and the finest international cuisine, Dubai has more than enough depth to satisfy even the most seasoned of travellers.

Dubai is an upcoming global leader in medical innovation and research. About $177.5 million revenue generated from medical tourism in 2012, which may rise to $710 million by 2020. The medical tourism is expected to attract more than 500,000 patients per year and boost its economy by up to $2.6 billion by 2020..

Conference Highlights:

· Central nervous system disorders

· Cerebral Disorders

· Neuronal Disorders

· CNS and Neurosurgery

· Neurochemical Transmission

· Neuro-oncology and CNS

· Cognitive Neurology

· Spinal Cord

· Signal Transduction and CNS

· Gensis of Neurons

· Neuro Pharmaceutics

· Clincal Aspects of CNS

· Case Study on CNS

· Clinical Trials on CNS

· CNS Biomarkers

· Perspective in Neuroscience and Neurology

. Drug Metabolism in Drug Design

Why to attend???

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of CNS 2016.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://cns.conferenceseries.com/sponsors.php

Major Associations around the Globe

· Brain Injury Association of America

· The Brain and Behaviour Research Foundation

· Alzheimer's Association

· World Federation for Mental Health

· British Neuro-oncology Society

Market Analysis Report:

· The CNS disorders market may be segmented into numerous subcategories, including Alzheimer's disease (AD), epilepsy, insomnia, major depressive disorder (MDD), Parkinson's disease (PD), migraine, schizophrenia, attention-deficit hyperactivity disorder (ADHD), bipolar disorder among others. Antipsychotics were the largest CNS drug class. Patent expirations of key brands Seroquel and Zyprexa will form the main resistors to segmental growth through 2016.

· In 2013-14 Alzheimer’s Research UAE spent approx. £8.7m on research projects. They focused projects into Alzheimer’s and dementia types such as vascular dementia frontotemporal dementia and Lewy bodies dementia.

· The Global Acute Ischemic Stroke (AIS) market predicted an increase in rate of stroke market growth of 3.4 % from $2.9 billion in 2008 to $3.6 billion by 2015.

· Brain Research through Advancing Innovative neurotechnologies is a research effort launched by the Obama Administration to map the human brain working. In FY 2014, a $100 million fund was issued in name of the National Institutes of Health.

· The Human Brain Project is the one of the longest running project; the project cost is estimated at 1.19 billion euros and planned to last ten years (2013-2023).

· Parkinson Society Canada, Funding: $1,628,076, Duration: December 1, 2009 - March 31, 2014.

· Millennium Research Group reported in January 2014 the global market for spinal non fusion will nearly triple in size through 2022. It is expected to surpass $1.6 billion, driven by the emerging Asia Pacific, Brazil, India and China markets. The Asia Pacific spinal implant and bone growth substitute market is projected to reach $7 billion by 2022, according to a Decision Resources Group report.

Target Audience:

Directors, neurologist, neurosurgeons, neuro-oncologists, neuroradiologists, neuroscientists, psychiatrist, head of department, Professors and Students from Academia in the research of Neuroscience and neurology.

Major Organizations Dealing with Central Nervous System Disorders around the World

· American Association of Neurological Surgeons

· British Paediatric Neurology Association

· National Institute-Neurological

· American Academy of Neurology

· European Neurological Societies

· World Federation of Neurology

· Spanish Society of Neurology

· Neuro-Developmental Treatment Association

Organizations Dealing with Central Nervous System Disorders in UAE

· Stroke Association, UAE

· The World Federation of Neurosurgical Societies

· British Association of Stroke Physicians (BASP) – UAE

· Saudi Association of Neurosurgery, UAE

· Emirates Medical Association, UAE

Organizations Dealing with Central Nervous System Disorders in Dubai

· Dubai Health Authority

· The American Centre for Psychiatry and Neurology, Dubai

· Dubai Neurology , Dubai

· American Heart Association, Dubai

· Dubai Bone & Joint Centre

· Armada Medical Centre, Dubai

Universities working on Central Nervous System disorders in Worldwide

· Stanford University

· University of California

· University of South Carolina Beauport

· University of Helsinki

· California Institute of Technology

· Yale University

· Harvard University

· University of Pennsylvania

· University of Chicago

· The Kavli Institute for Brain Science

· Cornell University

· Johns Hopkins University

· North-western University

· Sydney Medical School

· Institute for Stroke and Dementia Research, Munich

· The Ohio State University

Universities associated with Central Nervous System Disorders research in UAE

· Alfaisal University, Saudi Arabia

· King Saud bin Abdulaziz University, UAE

· Umm Al-Qura University, UAE

· American university of Beirut, Lebanon

· University of Sharjah, Sharjah

· Imam Muhammad ibn Saud Islamic University

· University of Dammam, Riyadh

· King Khalid University, Saudi Arabia

· United Arab Emirates University

Universities associated with Central Nervous System Disorders research in Dubai

· Dubai Medical College, Dubai

· Al Zahra Medical college, Dubai

· Jumeria University, Dubai

· College of Medicine , Dubai

· American University in the Emirates, Dubai

· RAK Medical and Health University, Dubai

Hospitals treating Central Nervous System Disorders across the globe

· Cleveland Clinic

· St Jude Children's Research Hospital

· Johns Hopkins Medicine

· Mayo Clinic Scottsdale AZ

· Massachusetts General Hospital

· Memorial Sloan Kettering Cancer Centre

· New York Presbyterian / Lower Manhattan Hospital

· Deer's Head Hospital Centre

· Montreal Neurological institute and Hospital

· St George’s Hospital

Hospitals with treatment for Central Nervous System Disorders in UAE

· Sheikh Khalifa Medical City, Abu Dhabi

· RAK Hospital, UAE

· Zulekha Hospital, Sharjah

· Neuro Spinal Hospital, Dubai

· Canadian Specialist hospital , Dubai

· German neuroscience centre

· NMC speciality hospital

· Al Zahra hospital, Dubai

· American Centre for Psychiatry & Neurology, Dubai

· Dubai hospital, Al Baraha

Hospitals with treatment for Central Nervous System Disorders in Dubai

· Neuro Spinal Hospital, Dubai

· Al Zahra hospital, Dubai

· American Center for Psychiatry & Neurology, Dubai

· Rashid Hospital, Dubai

· Prime Hospital Dubai

· Mediclinic Hospital, Dubai

· American Hospital, Dubai

Societies Associated with Central Nervous System Disorders in World

· American Society of Neuro-rehabilitation, USA

· Albanian Alzheimer Society

· International Brain Research organization (IBRO)

· Stroke Society Of Australasia - AUSTRALIA

· National Brain Tumour Society

· Canadian Stroke Consortium - CANADA

· The Chinese Stroke Association (CSA) – CHINA

· The Japan Stroke Society – JAPAN

· British Neuro-Oncology Society

· Romanian National Stroke Association – ROMANIA

· European Stroke Organization – SWITZERLAND

· National Multiple Sclerosis Society

· International Parkinson and Movement Disorders Society – USA

Societies Associated with Central Nervous System Disorders in UAE

· Society for Arab Neuroscientist, Saudi Arabia

· Riyadh Neurosciences Club

· Saudi Neurological Society, Riyadh

· Saudi Association of Neurological Surgery

· Pan Arab Neurosurgical Society

Societies Associated with Central Nervous System Disorders in Dubai

· Emirates Neuroscience Society

· Emirates Neurology Society

· German Neuroscience centre

Companies Associated with Central Nervous System Disorders and Therapeutics Research in World

· Abbott Laboratories

· Cordis Corporation

· Boston Scientific Corporation

· Genentech, Inc.

· Innovative NeuroTechnologies

· Medtronic plc

· GE Healthcare

· Stryker Corporation

· Medivation

· Impax labs

· NeuroNascent

· Genzyme

· AstraZeneca

· Forest Laboratories

· Chelsea Therapeutics

· NeuroWave Systems

· Serina Therapeutics

Companies Associated with Central Nervous System Disorders and Therapeutics Research in UAE

· Pfizer UAE

· Johnson & Johnson Middle East

· Novo Nordisk Pharma Gulf

· Gulf Pharmaceutical Industry-Julphar (JULPHAR)

· Smart Health and Nutrition Ltd.

· Hikma Pharmaceuticals PLC

· Valeant Pharmaceuticals MEA FZ LLC

· Sanofi Aventis UAE

· Astra Zeneca UAE

· Gulf Inject

Companies Associated with Central Nervous System Disorders in Dubai

· AbbVie Biopharmaceuticals GmbH, Dubai

· Merck Serono Middle East, Dubai

· Hospira, dubai

· AstraZeneca, Dubai

· Al-Hayat Pharmaceuticals

· Amgen

· Elis Pharmaceuticals Limited

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	December 05-07, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2	Day 3
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

2^nd International Conference on Central Nervous System Disorders and Therapeutics December 05-07, 2016 Dubai, UAE

Recommended Global Neuroscience Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links